Pfizer
Markets Comirnaty, the mRNA COVID-19 vaccine it developed with BioNTech.
US FDA, 23 Aug 2021Prices by TradingView, about 15 minutes delayed. Not investment advice.
- Ticker
- PFE · NYSE
- Based in
- United States
- Website
- pfizer.com ↗
How nano is it?
No filing of theirs says yet
We flag how much of a business is nanotechnology only when the company's own filings say it. Until then we describe what it makes.
On the record
Latest steps
The newest dated events on the technologies above.
- Approval
mRNA vaccines
The FDA fully approved the Pfizer-BioNTech vaccine, now sold as Comirnaty: the first COVID-19 vaccine to get full approval. Its review covered about 20,000 people who got the vaccine and 20,000 who got a placebo.
US FDA, 23 Aug 2021 - Widely usedCompany-reported
mRNA vaccines
Pfizer and BioNTech had supplied more than one billion doses of their COVID-19 vaccine, BioNTech said.
Reuters, 9 Aug 2021 - Approval
mRNA vaccines
The FDA authorized the Pfizer-BioNTech vaccine for emergency use in people 16 and older, based on a randomized, blinded trial in thousands of people.
US FDA, 23 Aug 2021
Not investment advice. We describe what companies do and what their own filings say; we never say whether to buy or sell.